Head of PV
Kate Chasmar
Kate Chasmar has over 18 years of experience in end-to-end clinical safety and pharmacovigilance. Her expertise was gained from working across small-to-medium CROs, specialist PV Providers and big Pharma. She has worked on all development and marketing stages, from small phase I studies through to large post-marketing portfolios. Her knowledge ranges across multiple product types (e.g., drugs, devices, combination, ATIMPs). Kate has led multiple teams responsible for clinical safety and post-marketing pharmacovigilance services for customers ranging from small biotech to large generic companies.